Blog

Recover faster with peptide therapy! Here are 3 game changing peptides shown to help aid in recovery post injury or surgery! 

Weight loss with tirzepatide was fairly consistent across different body mass index (BMI) ranges, ages, and number of obesity-related comorbidities in patients with overweight/obesity without type 2 diabetes. These were the findings about tirzepatide — the dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) agonist for obesity which was presented at ObesityWeek.

Fad diets come and go, but many simple "facts" tend to stick around through them all. Here's a look at four popular and persistent ideas around nutrition that are actually myths. 

Tirzepatide is a new class of medications being studied for the treatment of obesity. A once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor activator, Tirzepatide is a single peptide that triggers the body's receptors for GIP and GLP-1, two natural incretin hormones.

The most recent FDA approved weight loss medication, Semaglutide (also a GLP-1 activator) has been on the market for a while and has been a very successful option for weight loss. Countless patients here at Transformyou have had amazing results with Semaglutide. The new kid on the block looks to be Tirzepatide. Here are the details.